Case Study: Leveraging Dendritic Cell Biology to Improve NK-cell Based Therapeutic Approaches
Time: 9:00 am
day: Conference Day One
Details:
- Dendritic cell biology can be used to improve NK-cell based therapeutic approaches
- Intratumoral allogeneic dendritic cells activate NK cells and broader antitumour immune responses
- Leukemic-derived dendritic cells can be used to expand memory NK cells for therapeutic purposes
